Technical Analysis for VACC - Vaccitech plc

Grade Last Price % Change Price Change
C 16.77 6.48% 1.02
VACC closed up 6.48 percent on Friday, May 14, 2021, on 71 percent of normal volume. The bulls were able to push the stock to a new 52-week high.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical VACC trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
New 52 Week High Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
New 52 Week Closing High Bullish 6.48%
Gapped Up Strength 6.48%
Up 3 Days in a Row Strength 6.48%
Up 4 Days in a Row Strength 6.48%
Up 5 Days in a Row Strength 6.48%
Older End-of-Day Signals for VACC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 14 hours ago
Up 10% about 14 hours ago
Gap Up Partially Closed about 15 hours ago
New 52 Week High about 15 hours ago
Up 5% about 15 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Vaccitech plc Description

Vaccitech plc is a clinical-stage biopharmaceutical company that engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. Its therapeutic programs include VTP-300, indicated for the treatment of chronic hepatitis B infection; VTP-200, indicated for the treatment of human papilloma virus infection; VTP-850, indicated for the treatment of prostate cancer; and VTP-600, indicated for the treatment of non-small cell lung cancer. The company's prophylactic programs include VTP-400 for the prevention of herpes zoster or shingles; and VTP-500 for the prevention of Middle East respiratory syndrome. In addition, it is developing AZD1222, a COVID-19 vaccine. Vaccitech plc was formerly known as Vaccitech Rx Limited and changed its name to Vaccitech plc on March 31, 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, United Kingdom.


Keywords: Medicine Biopharmaceutical Clinical Medicine Infectious Diseases Cancers Prostate Cancer Non Small Cell Lung Cancer Vaccine Vaccination Medical Research Shingles Treatment Of Non Small Cell Lung Cancer Immunotherapeutics Treatment Of Prostate Cancer Vaccines Prevention Of Infectious Diseases

Is VACC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 17.87
52 Week Low 12.25
Average Volume 254,980
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 14.18
Average True Range 0.00
ADX 0.0
+DI 0.00
-DI 0.00
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.89
Resistance 3 (R3) 19.91 18.89 19.37
Resistance 2 (R2) 18.89 18.10 18.88 19.20
Resistance 1 (R1) 17.83 17.60 18.36 17.81 19.02
Pivot Point 16.81 16.81 17.08 16.80 16.81
Support 1 (S1) 15.75 16.02 16.28 15.73 14.52
Support 2 (S2) 14.73 15.52 14.72 14.34
Support 3 (S3) 13.67 14.73 14.17
Support 4 (S4) 13.65